Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Firms / Monograph Capital Advisors (uk), LLP

Monograph Capital Advisors (uk), LLP

Institutional venture firm · probableLondonmonograph.bioSEC venture capital fund adviserpart of Monograph Capital

One of 2 advisers that share monograph.bio; the firm is Monograph Capital. Monograph Capital Advisors, L.P.. Each keeps its own CRD, funds and filings; the grouping is the website each swore to on Form ADV and is recomputed every pass.

venture manager with no reported fund assets yet (scale unknown)

Importance
1
low
Active deployment
4
low
Emerging
0
low
Completeness
38
elevated
Freshness
97
high
Research priority
2
low
Identity and regulatory footprint
Headquarters
London, United Kingdomadviserinfo.sec.gov
Office address
LIBERTY HOUSE, 222 REGENT STREET, London, W1B 5TRadviserinfo.sec.gov
Business phone
4.47913E+11adviserinfo.sec.gov
Website
https://monograph.bio/
SEC adviser type
exempt reporting adviseradviserinfo.sec.gov
SEC exemption claimed
venture capital fund adviseradviserinfo.sec.govItem 2.B(1): advises solely venture capital funds
Latest Form ADV
Nov 1, 2024
Private funds reported
0 (0 venture capital funds)adviserinfo.sec.gov
Private fund gross assets
unknownreported GAV of the funds, the adviser's own number; not fund size, not dry powder
Owners on Schedule A
Monograph Capital Holdings, L.P. (Managing Member), D; Monograph Capital Holdings Advisors, LLC (General Partner), F
business phone
4.47913E+11adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
1 observed deals
Stated (the firm’s website)
Sectors
not stated or not yet read
Stages
not stated or not yet read
Geography
not stated
Check size
not stated; DFX does not estimate checks from round sizes
Observed (from deals on record)
Stage at participation
series b 100%
Stage at first entry
series b 100%
Sectors
unknown 100%
lead rate 0%follow-on rate 0%new logos, 12 months 1
Funds and vehicles
0 reported
No vehicle on record yet. A fund arrives from Form ADV Schedule D 7.B.(1) or a Form D filing.
Investment team
2 current, 0 departed
Charles Ronald Conn
Member · since Mar 1, 2021
Partner
FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Fred Cohen
Member · since Mar 1, 2021
Partner
FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Investments on record
1 edges, 1 companies, 0 partner-attributed
CompanyRoundRolePartnerRound sizeThis investorDateSource
Innovent's Partner Ollin BiosciencesSeries B · Series Bparticipantunknown$330MunknownJun 24, 2026Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS)
“This investor” is the amount disclosed for this investor alone; it is unknown unless a source said it. The round size is the whole round.
Co-investors
8 relationships from shared deals, counted for the whole firm
Asset Management Ventures, LLC 1 shared · one timeMenlo Ventures 1 shared · one timeArch Venture Partners 1 shared · one time · they led 1RA Capital Management, LP 1 shared · one timeCommodore Capital 1 shared · one timeTCGX 1 shared · one time · they led 1Blackstone Multi-Asset Investing 1 shared · one timeCanada Pension Plan Investment Board 1 shared · one time
Limited partners
0 disclosed
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Timeline
1 dated events
  1. Aug 16, 2021
    Monograph Capital first filed Form ADV (ERA, venture capital fund adviser exemption)
    First SEC adviser filingOrganizationFactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Classification history
  1. Sep 12, 2026
    Institutional venture firm (probable, 70%, cls-1)
    venture manager with no reported fund assets yet (scale unknown)
Evidence
18 observations from 1 source
Every observation behind this profile, with its source, date and class
FactValueEffectiveClassSource
SEC exemption claimedventure_capital_fund_adviserNov 1, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
SEC adviser typeexempt_reporting_adviserNov 1, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
First Form ADV filing2021-08-16Nov 1, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Adv history loadedadv-hist-1Sep 12, 2026FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Latest Form ADV filing2024-11-01Nov 1, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Venture share of reported funds0Nov 1, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Business phone4.47913E+11Nov 1, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
HeadquartersLondon, United KingdomNov 1, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Office addressLIBERTY HOUSE, 222 REGENT STREET, London, W1B 5TRNov 1, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Legal formLimited Liability PartnershipNov 1, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Private funds reported0Nov 1, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Venture funds reported0Nov 1, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Websitehttps://monograph.bio/Nov 1, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)